PWAM
UROV

Park West Asset Management’s Urovant Sciences Ltd. UROV Stock Holding History

Park West Asset Management’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-224,215
Closed -$2.07M – 85
2020
Q1 		$2.07M Sell
224,215
-208,285
-48% -$2.51M 0.14% 56
2019
Q4 		$6.71M Hold
432,500
– – 0.28% 61
2019
Q3 		$4.1M Hold
432,500
– – 0.2% 61
2019
Q2 		$3.42M Hold
432,500
– – 0.14% 73
2019
Q1 		$4.35M Sell
432,500
-42,500
-9% -$436K 0.19% 74
2018
Q4 		$3.13M Sell
475,000
-50,000
-10% -$455K 0.15% 76
2018
Q3 		$6.3M Buy
+525,000
New +$6.21M 0.23% 73

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Park West Asset Management's UROV Position: Q2 2020 in Review

Park West Asset Management sold out of Urovant Sciences Ltd. (UROV) in Q2 2020, closing a stake of 224,215 shares — an estimated $2.07M sold.

Park West Asset Management first reported a position in UROV in Q3 2018 and held it in 7 quarters. The position peaked at $6.71M in Q4 2019. 25 funds tracked by Wall St. Rank hold UROV as of Q2 2020.

  • Park West Asset Management reported no remaining Urovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
  • Park West Asset Management sold 224,215 Urovant Sciences Ltd. shares in Q2 2020, an estimated $2.07M.
  • Park West Asset Management first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 7 quarters.
  • Park West Asset Management's Urovant Sciences Ltd. position peaked at $6.71M in Q4 2019.
  • 25 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q2 2020.

Based on Park West Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.